Danes get advice on EU innovation funding:
This article was originally published in Clinica
Executive Summary
Danish industry is receiving a helping hand from its trade association to benefit from R&D funding available under the EU's 6th framework programme (FP6). Medicoindustrien is holding a meeting on September 24 on how companies can obtain funding. An EU consultant will provide an overview of the framework programme, with special focus on the two areas relevant for the medical device industry - the LifeScience Programme (biotech) and the Nano Programme (materials). There will also be reports from those experienced in obtaining funding for medical devices under EU framework programmes.
You may also be interested in...
The Dog That Didn’t Bark: ODAC Gives Nod To Three Products Despite Negative FDA Reviews
Oncologic Drugs Advisory Committee was swayed by views of its disease area experts in favorably reporting out Geron’s imetelstat for myelodysplastic syndromes and supplemental applications for the CAR-T products Carvykti and Abecma in earlier lines of multiple myeloma.
Demi Moore’s Wonderbelly Antacid Investment Lands Supporting Role In Her Promotional Posts
Wonderbelly Antacids “free from” ad claims work but failing to disclose Demi Moore is an investor in her promotions doesn’t, NAD says. Dakota Nutrition fails again on NAD’s test of its testing for elderberry in its supplements.
UroGen Approaches A Big Expansion In Bladder Cancer
The oncology company is preparing for the launch of UGN-102 for bladder cancer. CEO Liz Barrett talked to Scrip about the company’s next growth phase.